Client Profile

Customer Since: 2024

Employees: 1500

Sector: Biopharmaceutical

Addressing Oracle operational challenges and transformation needs  

A major global biopharmaceutical organisation was facing significant operational challenges with its enterprise Oracle ecosystem, which underpins critical functions such as finance, planning, supply chain, and data integration. The company’s rapid growth and evolving regulatory landscape demanded a support partner capable of delivering both agility and reliability. Previous support arrangements had not kept pace with business needs, resulting in slow technology rollouts and limited capacity for continuous improvement. The organisation needed to overcome these barriers to maintain compliance, optimise performance, and enable ongoing innovation across its global operations. 

Version 1 was selected to deliver a seamless transition, expert management, and a proactive programme of enhancements, ensuring the client could realise measurable business value and accelerate its strategic objectives.

Implementing a high-performance Oracle ecosystem for growth 

  • We provided an onshore team of Oracle specialists, operating as an extension of the client’s in-house team and fostering a collaborative, trust-based relationship. 
  • The transition was completed within six weeks, earning a perfect score for professionalism and expertise. 
  • A continuous improvement programme delivered 20 enhancements within six months, driving operational efficiency and supporting business growth. 
  • Improved testing and automation ensured compliance with regulatory requirements, reducing risk and supporting agile business operations. 
  • The partnership enabled the client to roll out new technology at pace, maintaining high performance and supporting ambitious growth targets. 

Oracle cost and compliance wins 

  • Rapid transition minimised disruption and accelerated value realisation.  
  • Continuous improvements and automation delivered measurable cost savings and operational efficiencies.  
  • Enhanced compliance and risk management supported the company’s global expansion and regulatory commitments.